Stay updated on Nivolumab/Daratumumab in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab/Daratumumab in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab/Daratumumab in Multiple Myeloma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    PubMed publications note updated to indicate automatic filling from PubMed and Revision: v3.3.2; the previous PubMed note and Revision: v3.2.0 were removed.
    Difference
    0.1%
    Check dated 2025-11-24T21:45:09.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The funding-status notice at the top of the page was removed; this does not affect the study details or eligibility information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-17T20:04:40.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    No additions or deletions were detected; the page content appears unchanged.
    Difference
    0.2%
    Check dated 2025-11-03T13:48:49.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a new field labeled 'Last Update Posted (Estimated)' on the Study Details page and removed the previous 'Last Update Posted' field.
    Difference
    0.0%
    Check dated 2025-10-27T10:47:16.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Updated version to v3.2.0 and added a government operating-status notice for NIH Clinical Center, directing users to cc.nih.gov and opm.gov.
    Difference
    2%
    Check dated 2025-10-06T04:21:59.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Core terminology updated from 'Plasma cell myeloma' to 'Multiple myeloma' and page revision incremented from v3.0.2 to v3.1.0, indicating an updated version of the page.
    Difference
    0.1%
    Check dated 2025-09-28T23:37:16.000Z thumbnail image

Stay in the know with updates to Nivolumab/Daratumumab in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab/Daratumumab in Multiple Myeloma Clinical Trial page.